Literature DB >> 23813048

Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients.

Gennaro Galizia1, Marica Gemei, Michele Orditura, Ciro Romano, Anna Zamboli, Paolo Castellano, Andrea Mabilia, Annamaria Auricchio, Ferdinando De Vita, Luigi Del Vecchio, Eva Lieto.   

Abstract

INTRODUCTION: Circulating tumor cells are thought to play a crucial role in the development of distant metastases. Their detection in the blood of colorectal cancer patients may be linked to poor outcome, but current evidence is controversial.
MATERIALS AND METHODS: Pre- and postoperative flow cytometric analysis of blood samples was carried out in 76 colorectal cancer patients undergoing surgical resection. The EpCAM/CD326 epithelial surface antigen was used to identify circulating tumor cells.
RESULTS: Fifty-four (71%) patients showed circulating tumor cells preoperatively, and all metastatic patients showed high levels of circulating tumor cells. Surgical resection resulted in a significant decrease in the levels of circulating tumor cells. Among 69 patients undergoing radical surgery, 16 had high postoperative levels of circulating tumor cells, and 12 (75%) experienced tumor recurrence. High postoperative level of circulating tumor cells was the only independent variable related to cancer relapse. In patients without circulating tumor cells, the progression-free survival rate increased from 16 to 86%, with a reduction in the risk of tumor relapse greater than 90%.
CONCLUSIONS: High postoperative levels of circulating tumor cells accurately predicted tumor recurrence, suggesting that assessment of circulating tumor cells could optimize tailored management of colorectal cancer patients.

Entities:  

Mesh:

Year:  2013        PMID: 23813048     DOI: 10.1007/s11605-013-2258-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  45 in total

Review 1.  Progress in the development of prognostic and predictive markers for gastrointestinal malignancies.

Authors:  Crystal S Denlinger; Steven J Cohen
Journal:  Curr Treat Options Oncol       Date:  2007-10

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

3.  CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.

Authors:  Marica Gemei; Peppino Mirabelli; Rosa Di Noto; Claudia Corbo; Antonino Iaccarino; Anna Zamboli; Giancarlo Troncone; Gennaro Galizia; Eva Lieto; Luigi Del Vecchio; Francesco Salvatore
Journal:  Cancer       Date:  2012-10-01       Impact factor: 6.860

4.  Genetic detection of colorectal cancer cells in circulation and lymph nodes.

Authors:  S Nakamori; M Kameyama; H Furukawa; O Takeda; S Sugai; S Imaoka; Y Nakamura
Journal:  Dis Colon Rectum       Date:  1997-10       Impact factor: 4.585

5.  Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

Authors:  Matthew G Krebs; Jian-Mei Hou; Robert Sloane; Lee Lancashire; Lynsey Priest; Daisuke Nonaka; Tim H Ward; Alison Backen; Glen Clack; Andrew Hughes; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

6.  Circulating tumour cells in non-metastatic breast cancer: a prospective study.

Authors:  Anthony Lucci; Carolyn S Hall; Ashutosh K Lodhi; Anirban Bhattacharyya; Amber E Anderson; Lianchun Xiao; Isabelle Bedrosian; Henry M Kuerer; Savitri Krishnamurthy
Journal:  Lancet Oncol       Date:  2012-06-06       Impact factor: 41.316

Review 7.  Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients.

Authors:  Bela Molnar; Ferenc Sipos; Orsolya Galamb; Zsolt Tulassay
Journal:  Dig Dis       Date:  2003       Impact factor: 2.404

8.  Practical utility of circulating tumour cells as biomarkers in cancer chemotherapy for advanced colorectal cancer.

Authors:  Kazunori Otsuka; Hiroo Imai; Hiroshi Soeda; Keigo Komine; Chikashi Ishioka; Hiroyuki Shibata
Journal:  Anticancer Res       Date:  2013-02       Impact factor: 2.480

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  Circulating tumor cells measurements in hepatocellular carcinoma.

Authors:  Franck Chiappini
Journal:  Int J Hepatol       Date:  2012-05-28
View more
  19 in total

1.  Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.

Authors:  Lili Wang; Shichao Zhou; Wenying Zhang; Jiongyi Wang; Meiling Wang; Xiaohua Hu; Feng Liu; Yanjie Zhang; Bin Jiang; Haihua Yuan
Journal:  Int J Colorectal Dis       Date:  2019-01-10       Impact factor: 2.571

2.  The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.

Authors:  Tsuyoshi Ozawa; Soichiro Ishihara; Takeshi Nishikawa; Toshiaki Tanaka; Junichiro Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2015-06-07       Impact factor: 2.571

3.  Tumor cells are dislodged into the pulmonary vein during lobectomy.

Authors:  Xiaosai Yao; Christina Williamson; Viktor A Adalsteinsson; Richard S D'Agostino; Torin Fitton; Gregory G Smaroff; Robert T William; K Dane Wittrup; J Christopher Love
Journal:  J Thorac Cardiovasc Surg       Date:  2014-07-23       Impact factor: 5.209

Review 4.  Tumor circulome in the liquid biopsies for digestive tract cancer diagnosis and prognosis.

Authors:  Long Chen; Yu Chen; Yuan-Ling Feng; Yan Zhu; Li-Quan Wang; Shen Hu; Pu Cheng
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 5.  Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-22       Impact factor: 4.254

6.  CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence.

Authors:  Eva Lieto; Gennaro Galizia; Michele Orditura; Ciro Romano; Anna Zamboli; Paolo Castellano; Andrea Mabilia; Annamaria Auricchio; Ferdinando DE Vita; Marica Gemei
Journal:  Oncol Lett       Date:  2014-12-01       Impact factor: 2.967

Review 7.  Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review.

Authors:  J W Boland; K McWilliams; S H Ahmedzai; A G Pockley
Journal:  Br J Cancer       Date:  2014-07-15       Impact factor: 7.640

8.  Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study.

Authors:  Lucília P Pereira; Patrícia Silva; Marlene Duarte; Liliana Rodrigues; Catarina M M Duarte; Cristina Albuquerque; Ana Teresa Serra
Journal:  Nutrients       Date:  2017-04-10       Impact factor: 5.717

9.  Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients.

Authors:  Wen-Sy Tsai; Jinn-Shiun Chen; Hung-Jen Shao; Jen-Chia Wu; Jr-Ming Lai; Si-Hong Lu; Tsung-Fu Hung; Yen-Chi Chiu; Jeng-Fu You; Pao-Shiu Hsieh; Chien-Yuh Yeh; Hsin-Yuan Hung; Sum-Fu Chiang; Geng-Ping Lin; Reiping Tang; Ying-Chih Chang
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

10.  A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.

Authors:  Xianglei Wu; Romina Mastronicola; Qian Tu; Gilbert Charles Faure; Marcelo De Carvalho Bittencourt; Gilles Dolivet
Journal:  BMC Cancer       Date:  2016-07-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.